These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 35192933)

  • 1. Long noncoding RNA LINC01234 promotes hepatocellular carcinoma progression through orchestrating aspartate metabolic reprogramming.
    Chen M; Zhang C; Liu W; Du X; Liu X; Xing B
    Mol Ther; 2022 Jun; 30(6):2354-2369. PubMed ID: 35192933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429.
    Sui CJ; Zhou YM; Shen WF; Dai BH; Lu JJ; Zhang MF; Yang JM
    J Mol Med (Berl); 2016 Nov; 94(11):1281-1296. PubMed ID: 27380494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Argininosuccinate synthase 1 suppresses tumor progression through activation of PERK/eIF2α/ATF4/CHOP axis in hepatocellular carcinoma.
    Kim S; Lee M; Song Y; Lee SY; Choi I; Park IS; Kim J; Kim JS; Kim KM; Seo HR
    J Exp Clin Cancer Res; 2021 Apr; 40(1):127. PubMed ID: 33838671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA AWPPH promotes hepatocellular carcinoma progression through YBX1 and serves as a prognostic biomarker.
    Zhao X; Liu Y; Yu S
    Biochim Biophys Acta Mol Basis Dis; 2017 Jul; 1863(7):1805-1816. PubMed ID: 28428004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel lncRNA RP11-386G11.10 reprograms lipid metabolism to promote hepatocellular carcinoma progression.
    Xu K; Xia P; Gongye X; Zhang X; Ma S; Chen Z; Zhang H; Liu J; Liu Y; Guo Y; Yao Y; Gao M; Chen Y; Zhang Z; Yuan Y
    Mol Metab; 2022 Sep; 63():101540. PubMed ID: 35798238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Argininosuccinate synthase 1 suppresses cancer cell invasion by inhibiting STAT3 pathway in hepatocellular carcinoma.
    Tao X; Zuo Q; Ruan H; Wang H; Jin H; Cheng Z; Lv Y; Qin W; Wang C
    Acta Biochim Biophys Sin (Shanghai); 2019 Mar; 51(3):263-276. PubMed ID: 30883650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OGDHL silencing promotes hepatocellular carcinoma by reprogramming glutamine metabolism.
    Dai W; Xu L; Yu X; Zhang G; Guo H; Liu H; Song G; Weng S; Dong L; Zhu J; Liu T; Guo C; Shen X
    J Hepatol; 2020 May; 72(5):909-923. PubMed ID: 31899205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
    Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH
    J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long noncoding RNA LINC00662 promotes M2 macrophage polarization and hepatocellular carcinoma progression via activating Wnt/β-catenin signaling.
    Tian X; Wu Y; Yang Y; Wang J; Niu M; Gao S; Qin T; Bao D
    Mol Oncol; 2020 Feb; 14(2):462-483. PubMed ID: 31785055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA LINC01503 promotes the progression of hepatocellular carcinoma via activating MAPK/ERK pathway.
    Wang MR; Fang D; Di MP; Guan JL; Wang G; Liu L; Sheng JQ; Tian DA; Li PY
    Int J Med Sci; 2020; 17(9):1224-1234. PubMed ID: 32547318
    [No Abstract]   [Full Text] [Related]  

  • 11. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.
    He H; Wang Y; Ye P; Yi D; Cheng Y; Tang H; Zhu Z; Wang X; Jin S
    J Exp Clin Cancer Res; 2020 Aug; 39(1):159. PubMed ID: 32795316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA LINC01234 promoted cell proliferation and invasion via miR-1284/TRAF6 axis in colorectal cancer.
    Liao X; Zhan W; Zhang J; Cheng Z; Li L; Tian T; Yu L; Li R
    J Cell Biochem; 2020 Oct; 121(10):4295-4309. PubMed ID: 31904146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA LINC01234 silencing exerts an anti-oncogenic effect in esophageal cancer cells through microRNA-193a-5p-mediated CCNE1 downregulation.
    Ma J; Han LN; Song JR; Bai XM; Wang JZ; Meng LF; Li J; Zhou W; Feng Y; Feng WR; Ma JJ; Hao JT; Shen ZQ
    Cell Oncol (Dordr); 2020 Jun; 43(3):377-394. PubMed ID: 32130660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA HULC promotes hepatocellular carcinoma progression.
    Zhang H; Liao Z; Liu F; Su C; Zhu H; Li Y; Tao R; Liang H; Zhang B; Zhang X
    Aging (Albany NY); 2019 Oct; 11(20):9111-9127. PubMed ID: 31645479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway.
    Li Y; Liu G; Li X; Dong H; Xiao W; Lu S
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2826-2832. PubMed ID: 30115383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
    Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
    Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulated lncRNA TP73-AS1 reduces radioresistance in hepatocellular carcinoma via the PTEN/Akt signaling pathway.
    Song W; Zhang J; Xia Q; Sun M
    Cell Cycle; 2019 Nov; 18(22):3177-3188. PubMed ID: 31564201
    [No Abstract]   [Full Text] [Related]  

  • 18. The role and mechanism of noncoding RNAs in regulation of metabolic reprogramming in hepatocellular carcinoma.
    Liao W; Du J; Wang Z; Feng Q; Liao M; Liu H; Yuan K; Zeng Y
    Int J Cancer; 2022 Aug; 151(3):337-347. PubMed ID: 35460073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. lncRNA MIAT promotes proliferation and invasion of HCC cells via sponging miR-214.
    Huang X; Gao Y; Qin J; Lu S
    Am J Physiol Gastrointest Liver Physiol; 2018 May; 314(5):G559-G565. PubMed ID: 29097358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRNDE acts as an epigenetic modulator of the p300/YY1 complex to promote HCC progression and therapeutic resistance.
    Liu YC; Lin YH; Chi HC; Huang PS; Liao CJ; Liou YS; Lin CC; Yu CJ; Yeh CT; Huang YH; Lin KH
    Clin Epigenetics; 2022 Aug; 14(1):106. PubMed ID: 35999564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.